Does Medicare Cover GLP-1 Medications?
Medicare coverage for GLP-1 medications has been evolving rapidly. Medicare Part D covers GLP-1 medications prescribed for type 2 diabetes (Ozempic, Mounjaro). The landmark expansion of Medicare to cover anti-obesity medications has been a major development in 2025-2026, with Wegovy and Zepbound becoming available under certain Part D plans.
Reviewed by GlobalGLP1 Editorial Team • Updated April 2026 • Sources: publicly available formulary data
Medication Coverage
| Medication | Status | Tier | Notes |
|---|---|---|---|
| Ozempic (semaglutide) | Covered | Part D Formulary | Covered for type 2 diabetes under Medicare Part D. Subject to plan-specific formulary placement and cost-sharing. Not covered for off-label weight loss. |
| Wegovy (semaglutide) | Varies | Part D (expanding) | FDA-approved for weight management. Medicare coverage expanding through legislative and CMS policy changes. Check your specific Part D plan for current status. |
| Mounjaro (tirzepatide) | Covered | Part D Formulary | Covered for type 2 diabetes. Strong formulary position across most Part D plans. |
| Zepbound (tirzepatide) | Varies | Part D (expanding) | FDA-approved for weight management. Coverage under Medicare is expanding. Check your specific Part D plan. |
| Saxenda (liraglutide) | Varies | Part D (limited) | Limited Part D coverage. Being replaced by newer options on most formularies. |
| Compounded semaglutide | Not Covered | N/A | Medicare does not cover compounded medications. |
Prior Authorization
Medicare Part D plans typically require prior authorization for GLP-1 medications. The process involves your prescriber submitting a coverage determination request to your Part D plan. Plans must respond within 72 hours for standard requests and 24 hours for expedited requests.
Cost Estimates
Savings tip: The Inflation Reduction Act capped out-of-pocket Part D costs at $2,000/year starting in 2025. This significantly reduces the annual cost burden for expensive GLP-1 medications. Extra Help (Low Income Subsidy) can further reduce costs.
Requirements for Coverage
- Active Medicare Part D enrollment
- Type 2 diabetes diagnosis (for Ozempic/Mounjaro)
- For weight management: coverage expanding — check your specific Part D plan
- Prior authorization from Part D plan
- Prescriber must be enrolled in Medicare
Tips for Getting Approved
Use Medicare Plan Finder (medicare.gov) during open enrollment to compare Part D plans for GLP-1 coverage
The $2,000 annual out-of-pocket cap (starting 2025) helps manage costs for expensive GLP-1 medications
Medicare Advantage plans may offer additional prescription drug benefits beyond standard Part D
Apply for Extra Help (Low Income Subsidy) if your income qualifies — it dramatically reduces drug costs
Ask your doctor about the Medicare Diabetes Prevention Program for complementary support
Approval Statistics
Medicare Part D covers GLP-1s well for diabetes. Weight management coverage is expanding under the Inflation Reduction Act but remains limited in 2026. Medicare Advantage plans may offer broader coverage than Original Medicare.
Common Denial Reasons & How to Avoid Them
How to avoid: Traditional Medicare Part D does not cover anti-obesity medications. Check if your Medicare Advantage plan includes this benefit, or explore manufacturer patient assistance programs.
How to avoid: Your doctor must submit a formal coverage determination request. Call 1-800-MEDICARE or your plan to start the process.
How to avoid: Ensure your doctor codes the correct diagnosis. For diabetes coverage, A1C documentation and type 2 diabetes diagnosis (E11.x) are required.
How to avoid: Each Part D plan has a different formulary. During Annual Enrollment (Oct-Dec), compare plans on Medicare.gov to find one that covers your specific GLP-1.
Step Therapy Requirements
Metformin first-line. Most Part D plans require documented A1C >7% despite metformin before approving GLP-1. Some plans may require trial of sulfonylurea or SGLT2 inhibitor.
Limited Part D coverage. Some Medicare Advantage plans covering weight management require BMI 30+ with comorbidity documentation and physician-supervised diet attempt.
Frequently Asked Questions
Yes, Medicare Part D covers Ozempic for type 2 diabetes management. Coverage, tier placement, and cost-sharing vary by your specific Part D plan. Use medicare.gov Plan Finder to check your plan's formulary.
Medicare coverage for anti-obesity medications like Wegovy has been expanding through legislative and regulatory changes. Check your specific Part D plan for current coverage. The Treat and Reduce Obesity Act has been a key driver of expanded coverage.
Costs depend on your Part D plan's formulary tier, deductible, and coverage phase. The $2,000 annual out-of-pocket cap (effective 2025) limits your maximum yearly spending. In the coverage gap phase, you'll pay no more than 25% of the drug cost.
Yes, during Medicare Open Enrollment (October 15 - December 7), you can switch Part D plans. Use Medicare Plan Finder to compare plans specifically for GLP-1 medication coverage and costs in your area.
Medicare Part D covers Mounjaro for type 2 diabetes but not for off-label weight loss. Zepbound, which is FDA-approved for weight management, is gaining Medicare coverage as anti-obesity medication policies expand. Check your Part D plan's current formulary for the latest status.
No, federal law prohibits using manufacturer savings cards or copay assistance programs with Medicare, Medicaid, and other government-funded insurance. However, the $2,000 annual Part D out-of-pocket cap and Extra Help (Low Income Subsidy) program can significantly reduce your costs.
The coverage gap (formerly called the "donut hole") is the phase between your initial coverage limit and catastrophic coverage. During this phase, you pay no more than 25% of the drug cost. With the $2,000 annual out-of-pocket cap effective since 2025, your total yearly spending is limited regardless of your medication costs.
Find Medicare GLP-1 Clinics by State
Explore More Resources
Find a GLP-1 Clinic That Takes Your Insurance
Search our directory of 2,770 clinics and filter by insurance, medication, and telehealth availability.
Disclaimer: Insurance coverage information is based on publicly available formulary data and may not reflect your specific plan. Coverage, cost, and requirements can change. Always verify with your insurer directly before making treatment decisions.